{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T23:29:46Z","timestamp":1794266986352,"version":"4.9.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,5]],"date-time":"2023-12-05T00:00:00Z","timestamp":1701734400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,5]],"date-time":"2023-12-05T00:00:00Z","timestamp":1701734400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The \u2018Yangcheng Scholar\u2019 Grant of Guangzhou","award":["202032768"],"award-info":[{"award-number":["202032768"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82170428"],"award-info":[{"award-number":["82170428"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","award":["(BB\/J004316\/1; BBS\/E\/D\/20221657)"],"award-info":[{"award-number":["(BB\/J004316\/1; BBS\/E\/D\/20221657)"]}],"id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Calcific aortic valve disease (CAVD) is the most common heart disease of the developed world. It has previously been established that metformin administration reduces arterial calcification via autophagy; however, whether metformin directly regulates CAVD has yet to be elucidated. In the present study we investigated whether metformin alleviates valvular calcification through the autophagy-mediated recycling of Runx2. Calcification was reduced in rat valve interstitial cells (RVICs) by metformin treatment (0.5\u20131.5\u00a0mM) (\n                    <jats:italic>P<\/jats:italic>\n                    \u2009&lt;\u20090.01), with a marked decrease in Runx2 protein expression compared to control cells (\n                    <jats:italic>P<\/jats:italic>\n                    \u2009&lt;\u20090.05). Additionally, upregulated expression of Atg3 and Atg7 (key proteins required for autophagosome formation), was observed following metformin treatment (1\u00a0mM). Blocking autophagic flux using Bafilomycin-A1 revealed colocalisation of Runx2 with LC3 puncta in metformin treated RVICs (\n                    <jats:italic>P<\/jats:italic>\n                    \u2009&lt;\u20090.001). Comparable Runx2 accumulation was seen in LC3 positive autolysosomes present within cells that had been treated with both metformin and hydroxychloroquine in combination (\n                    <jats:italic>P<\/jats:italic>\n                    \u2009&lt;\u20090.001). Mechanistic studies employing three-way co-immunoprecipitation with Runx2, p62 and LC3 suggested that Runx2 binds to LC3-II upon metformin treatment in VICs. Together these studies suggest that the utilisation of metformin may represent a novel strategy for the treatment of CAVD.\n                  <\/jats:p>","DOI":"10.1038\/s41598-023-47774-6","type":"journal-article","created":{"date-parts":[[2023,12,5]],"date-time":"2023-12-05T05:02:08Z","timestamp":1701752528000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Metformin ameliorates valve interstitial cell calcification by promoting autophagic flux"],"prefix":"10.1038","volume":"13","author":[{"given":"K.","family":"Phadwal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Koo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. E.","family":"MacRae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,5]]},"reference":[{"key":"47774_CR1","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1161\/CIRCULATIONAHA.110.006767","volume":"124","author":"NM Rajamannan","year":"2011","unstructured":"Rajamannan, N. M. et al. Calcific aortic valve disease: Not simply a degenerative process: A review and agenda for research from the national heart and lung and blood institute aortic stenosis working Group. Executive summary: Calcific aortic valve disease-2011 update. Circulation 124, 1783\u20131791. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.110.006767 (2011).","journal-title":"Circulation"},{"key":"47774_CR2","first-page":"1","volume":"13","author":"S Sehatzadeh","year":"2013","unstructured":"Sehatzadeh, S. et al. Transcatheter aortic valve implantation (TAVI) for treatment of aortic valve stenosis: an evidence update. Ont. Health Technol. Assess Ser. 13, 1\u201340 (2013).","journal-title":"Ont. Health Technol. Assess Ser."},{"key":"47774_CR3","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.jacc.2017.07.715","volume":"70","author":"T Rodriguez-Gabella","year":"2017","unstructured":"Rodriguez-Gabella, T., Voisine, P., Puri, R., Pibarot, P. & Rodes-Cabau, J. Aortic bioprosthetic valve durability: Incidence, mechanisms, predictors, and management of surgical and transcatheter valve degeneration. J. Am. Coll. Cardiol. 70, 1013\u20131028. https:\/\/doi.org\/10.1016\/j.jacc.2017.07.715 (2017).","journal-title":"J. Am. Coll. Cardiol."},{"key":"47774_CR4","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1161\/01.cir.103.11.1522","volume":"103","author":"ER Mohler 3rd","year":"2001","unstructured":"Mohler, E. R. 3rd. et al. Bone formation and inflammation in cardiac valves. Circulation 103, 1522\u20131528. https:\/\/doi.org\/10.1161\/01.cir.103.11.1522 (2001).","journal-title":"Circulation"},{"key":"47774_CR5","first-page":"449","volume":"20","author":"EL Monzack","year":"2011","unstructured":"Monzack, E. L. & Masters, K. S. Can valvular interstitial cells become true osteoblasts? A side-by-side comparison. J. Heart Valve Dis. 20, 449\u2013463 (2011).","journal-title":"J. Heart Valve Dis."},{"key":"47774_CR6","doi-asserted-by":"publisher","first-page":"I547","DOI":"10.1161\/CIRCULATIONAHA.105.001115","volume":"114","author":"L Osman","year":"2006","unstructured":"Osman, L., Yacoub, M. H., Latif, N., Amrani, M. & Chester, A. H. Role of human valve interstitial cells in valve calcification and their response to atorvastatin. Circulation 114, I547-552. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.105.001115 (2006).","journal-title":"Circulation"},{"key":"47774_CR7","doi-asserted-by":"publisher","first-page":"2985","DOI":"10.1002\/jcp.25935","volume":"232","author":"L Cui","year":"2017","unstructured":"Cui, L. et al. End stage renal disease-induced hypercalcemia may promote aortic valve calcification via Annexin VI enrichment of valve interstitial cell derived-matrix vesicles. J. Cell Physiol. 232, 2985\u20132995. https:\/\/doi.org\/10.1002\/jcp.25935 (2017).","journal-title":"J. Cell Physiol."},{"key":"47774_CR8","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1093\/cvr\/cvw205","volume":"112","author":"ME Lin","year":"2016","unstructured":"Lin, M. E. et al. Runx2 deletion in smooth muscle cells inhibits vascular osteochondrogenesis and calcification but not atherosclerotic lesion formation. Cardiovasc. Res. 112, 606\u2013616. https:\/\/doi.org\/10.1093\/cvr\/cvw205 (2016).","journal-title":"Cardiovasc. Res."},{"key":"47774_CR9","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1016\/j.ajpath.2015.03.020","volume":"185","author":"ME Lin","year":"2015","unstructured":"Lin, M. E., Chen, T., Leaf, E. M., Speer, M. Y. & Giachelli, C. M. Runx2 expression in smooth muscle cells is required for arterial medial calcification in mice. Am. J. Pathol. 185, 1958\u20131969. https:\/\/doi.org\/10.1016\/j.ajpath.2015.03.020 (2015).","journal-title":"Am. J. Pathol."},{"key":"47774_CR10","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1161\/CIRCRESAHA.112.267237","volume":"111","author":"Y Sun","year":"2012","unstructured":"Sun, Y. et al. Smooth muscle cell-specific runx2 deficiency inhibits vascular calcification. Circ Res 111, 543\u2013552. https:\/\/doi.org\/10.1161\/CIRCRESAHA.112.267237 (2012).","journal-title":"Circ Res"},{"key":"47774_CR11","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1001\/jama.2019.11505","volume":"322","author":"J Flory","year":"2019","unstructured":"Flory, J. & Lipska, K. Metformin for type 2 diabetes-reply. JAMA 322, 1313. https:\/\/doi.org\/10.1001\/jama.2019.11505 (2019).","journal-title":"JAMA"},{"key":"47774_CR12","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1001\/jama.2019.3805","volume":"321","author":"J Flory","year":"2019","unstructured":"Flory, J. & Lipska, K. Metformin in 2019. JAMA 321, 1926\u20131927. https:\/\/doi.org\/10.1001\/jama.2019.3805 (2019).","journal-title":"JAMA"},{"key":"47774_CR13","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.2337\/diacare.25.12.2244","volume":"25","author":"JA Johnson","year":"2002","unstructured":"Johnson, J. A., Majumdar, S. R., Simpson, S. H. & Toth, E. L. Decreased mortality associated with the use of metformin compared with sulfonylurea monotherapy in type 2 diabetes. Diabetes Care 25, 2244\u20132248. https:\/\/doi.org\/10.2337\/diacare.25.12.2244 (2002).","journal-title":"Diabetes Care"},{"key":"47774_CR14","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.bcp.2015.10.008","volume":"98","author":"S Ghosh","year":"2015","unstructured":"Ghosh, S. et al. Metformin improves endothelial function in aortic tissue and microvascular endothelial cells subjected to diabetic hyperglycaemic conditions. Biochem. Pharmacol. 98, 412\u2013421. https:\/\/doi.org\/10.1016\/j.bcp.2015.10.008 (2015).","journal-title":"Biochem. Pharmacol."},{"key":"47774_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2019.113787","volume":"174","author":"S Bahrambeigi","year":"2020","unstructured":"Bahrambeigi, S. & Shafiei-Irannejad, V. Immune-mediated anti-tumor effects of metformin; targeting metabolic reprogramming of T cells as a new possible mechanism for anti-cancer effects of metformin. Biochem. Pharmacol. 174, 113787. https:\/\/doi.org\/10.1016\/j.bcp.2019.113787 (2020).","journal-title":"Biochem. Pharmacol."},{"key":"47774_CR16","doi-asserted-by":"publisher","first-page":"538","DOI":"10.5604\/01.3001.0010.0284","volume":"16","author":"A Said","year":"2017","unstructured":"Said, A. & Akhter, A. Meta-analysis of randomized controlled trials of pharmacologic agents in non-alcoholic steatohepatitis. Ann. Hepatol. 16, 538\u2013547. https:\/\/doi.org\/10.5604\/01.3001.0010.0284 (2017).","journal-title":"Ann. Hepatol."},{"key":"47774_CR17","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1007\/s13679-019-00335-3","volume":"8","author":"A Yerevanian","year":"2019","unstructured":"Yerevanian, A. & Soukas, A. A. Metformin: Mechanisms in human obesity and weight loss. Curr. Obes. Rep. 8, 156\u2013164. https:\/\/doi.org\/10.1007\/s13679-019-00335-3 (2019).","journal-title":"Curr. Obes. Rep."},{"key":"47774_CR18","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3390\/jcm9092839","volume":"9","author":"CH Lu","year":"2020","unstructured":"Lu, C. H. et al. Metformin attenuates osteoporosis in diabetic patients with carcinoma in situ: A nationwide, retrospective, matched-cohort study in Taiwan. J. Clin. Med. 9, 22. https:\/\/doi.org\/10.3390\/jcm9092839 (2020).","journal-title":"J. Clin. Med."},{"key":"47774_CR19","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1111\/j.1464-5491.2005.01448.x","volume":"22","author":"JA Johnson","year":"2005","unstructured":"Johnson, J. A., Simpson, S. H., Toth, E. L. & Majumdar, S. R. Reduced cardiovascular morbidity and mortality associated with metformin use in subjects with Type 2 diabetes. Diabet. Med. 22, 497\u2013502. https:\/\/doi.org\/10.1111\/j.1464-5491.2005.01448.x (2005).","journal-title":"Diabet. Med."},{"key":"47774_CR20","doi-asserted-by":"publisher","first-page":"838","DOI":"10.3892\/etm.2020.8764","volume":"20","author":"J Du","year":"2020","unstructured":"Du, J. et al. Metformin attenuates cardiac remodeling in mice through the Nrf2\/Keap1 signaling pathway. Exp. Ther. Med. 20, 838\u2013845. https:\/\/doi.org\/10.3892\/etm.2020.8764 (2020).","journal-title":"Exp. Ther. Med."},{"key":"47774_CR21","doi-asserted-by":"publisher","first-page":"2568","DOI":"10.1161\/CIRCULATIONAHA.108.798561","volume":"119","author":"H Sasaki","year":"2009","unstructured":"Sasaki, H. et al. Metformin prevents progression of heart failure in dogs: Role of AMP-activated protein kinase. Circulation 119, 2568\u20132577. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.108.798561 (2009).","journal-title":"Circulation"},{"key":"47774_CR22","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.bbrc.2018.04.141","volume":"500","author":"F Liu","year":"2018","unstructured":"Liu, F. et al. Metformin ameliorates TGF-beta1-induced osteoblastic differentiation of human aortic valve interstitial cells by inhibiting beta-catenin signaling. Biochem. Biophys. Res. Commun. 500, 710\u2013716. https:\/\/doi.org\/10.1016\/j.bbrc.2018.04.141 (2018).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"47774_CR23","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s10020-021-00416-x","volume":"27","author":"Q En","year":"2021","unstructured":"En, Q., Zeping, H., Yuetang, W., Xu, W. & Wei, W. Metformin alleviates the calcification of aortic valve interstitial cells through activating the PI3K\/AKT pathway in an AMPK dependent way. Mol. Med. 27, 156. https:\/\/doi.org\/10.1186\/s10020-021-00416-x (2021).","journal-title":"Mol. Med."},{"key":"47774_CR24","doi-asserted-by":"publisher","first-page":"4303","DOI":"10.1002\/jcp.30887","volume":"237","author":"K Phadwal","year":"2022","unstructured":"Phadwal, K. et al. Metformin protects against vascular calcification through the selective degradation of Runx2 by the p62 autophagy receptor. J. Cell Physiol. 237, 4303\u20134316. https:\/\/doi.org\/10.1002\/jcp.30887 (2022).","journal-title":"J. Cell Physiol."},{"key":"47774_CR25","doi-asserted-by":"publisher","first-page":"2548","DOI":"10.1093\/cvr\/cvab267","volume":"118","author":"G Morciano","year":"2022","unstructured":"Morciano, G. et al. Impairment of mitophagy and autophagy accompanies calcific aortic valve stenosis favouring cell death and the severity of disease. Cardiovasc. Res. 118, 2548\u20132559. https:\/\/doi.org\/10.1093\/cvr\/cvab267 (2022).","journal-title":"Cardiovasc. Res."},{"key":"47774_CR26","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.3892\/mmr.2017.8163","volume":"17","author":"HG Tsang","year":"2018","unstructured":"Tsang, H. G. et al. Exploiting novel valve interstitial cell lines to study calcific aortic valve disease. Mol. Med. Rep. 17, 2100\u20132106. https:\/\/doi.org\/10.3892\/mmr.2017.8163 (2018).","journal-title":"Mol. Med. Rep."},{"key":"47774_CR27","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1002\/jbmr.3888","volume":"35","author":"NA Rashdan","year":"2020","unstructured":"Rashdan, N. A. et al. Osteocalcin regulates arterial calcification via altered Wnt signaling and glucose metabolism. J. Bone Miner Res. 35, 357\u2013367. https:\/\/doi.org\/10.1002\/jbmr.3888 (2020).","journal-title":"J. Bone Miner Res."},{"key":"47774_CR28","doi-asserted-by":"publisher","first-page":"4614","DOI":"10.1002\/jcp.30194","volume":"236","author":"FL Roberts","year":"2021","unstructured":"Roberts, F. L. et al. Osteoblast-specific deficiency of ectonucleotide pyrophosphatase or phosphodiesterase-1 engenders insulin resistance in high-fat diet fed mice. J. Cell Physiol. 236, 4614\u20134624. https:\/\/doi.org\/10.1002\/jcp.30194 (2021).","journal-title":"J. Cell Physiol."},{"key":"47774_CR29","doi-asserted-by":"publisher","first-page":"10004","DOI":"10.1038\/s41598-018-28296-y","volume":"8","author":"K Phadwal","year":"2018","unstructured":"Phadwal, K. et al. Spermine increases acetylation of tubulins and facilitates autophagic degradation of prion aggregates. Sci. Rep. 8, 10004. https:\/\/doi.org\/10.1038\/s41598-018-28296-y (2018).","journal-title":"Sci. Rep."},{"key":"47774_CR30","doi-asserted-by":"publisher","first-page":"8036","DOI":"10.1074\/jbc.M611473200","volume":"282","author":"Y Yamada","year":"2007","unstructured":"Yamada, Y. et al. The crystal structure of Atg3, an autophagy-related ubiquitin carrier protein (E2) enzyme that mediates Atg8 lipidation. J. Biol. Chem. 282, 8036\u20138043. https:\/\/doi.org\/10.1074\/jbc.M611473200 (2007).","journal-title":"J. Biol. Chem."},{"key":"47774_CR31","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.jmb.2017.12.002","volume":"430","author":"M Yamaguchi","year":"2018","unstructured":"Yamaguchi, M. et al. Atg7 activates an autophagy-essential ubiquitin-like protein Atg8 through multi-step recognition. J. Mol. Biol. 430, 249\u2013257. https:\/\/doi.org\/10.1016\/j.jmb.2017.12.002 (2018).","journal-title":"J. Mol. Biol."},{"key":"47774_CR32","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/cdd.2010.191","volume":"18","author":"R Kang","year":"2011","unstructured":"Kang, R., Zeh, H. J., Lotze, M. T. & Tang, D. The Beclin 1 network regulates autophagy and apoptosis. Cell Death Differ. 18, 571\u2013580. https:\/\/doi.org\/10.1038\/cdd.2010.191 (2011).","journal-title":"Cell Death Differ."},{"key":"47774_CR33","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1080\/15548627.2018.1474314","volume":"14","author":"M Mauthe","year":"2018","unstructured":"Mauthe, M. et al. Chloroquine inhibits autophagic flux by decreasing autophagosome-lysosome fusion. Autophagy 14, 1435\u20131455. https:\/\/doi.org\/10.1080\/15548627.2018.1474314 (2018).","journal-title":"Autophagy"},{"key":"47774_CR34","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1002\/jcp.25920","volume":"233","author":"X Sun","year":"2018","unstructured":"Sun, X. et al. TGF-beta inhibits osteogenesis by upregulating the expression of ubiquitin ligase SMURF1 via MAPK-ERK signaling. J. Cell Physiol. 233, 596\u2013606. https:\/\/doi.org\/10.1002\/jcp.25920 (2018).","journal-title":"J. Cell Physiol."},{"key":"47774_CR35","doi-asserted-by":"publisher","first-page":"28875","DOI":"10.1074\/jbc.274.41.28875","volume":"274","author":"Y Tintut","year":"1999","unstructured":"Tintut, Y., Parhami, F., Le, V., Karsenty, G. & Demer, L. L. Inhibition of osteoblast-specific transcription factor Cbfa1 by the cAMP pathway in osteoblastic cells. Ubiquitin\/proteasome-dependent regulation. J. Biol. Chem. 274, 28875\u201328879. https:\/\/doi.org\/10.1074\/jbc.274.41.28875 (1999).","journal-title":"J. Biol. Chem."},{"key":"47774_CR36","doi-asserted-by":"publisher","first-page":"3569","DOI":"10.1074\/jbc.M506761200","volume":"281","author":"R Shen","year":"2006","unstructured":"Shen, R. et al. Smad6 interacts with Runx2 and mediates Smad ubiquitin regulatory factor 1-induced Runx2 degradation. J. Biol. Chem. 281, 3569\u20133576. https:\/\/doi.org\/10.1074\/jbc.M506761200 (2006).","journal-title":"J. Biol. Chem."},{"key":"47774_CR37","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.cell.2010.01.028","volume":"140","author":"N Mizushima","year":"2010","unstructured":"Mizushima, N., Yoshimori, T. & Levine, B. Methods in mammalian autophagy research. Cell 140, 313\u2013326. https:\/\/doi.org\/10.1016\/j.cell.2010.01.028 (2010).","journal-title":"Cell"},{"key":"47774_CR38","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/ncb0310-207","volume":"12","author":"TE Rusten","year":"2010","unstructured":"Rusten, T. E. & Stenmark, H. p62, an autophagy hero or culprit?. Nat. Cell Biol. 12, 207\u2013209. https:\/\/doi.org\/10.1038\/ncb0310-207 (2010).","journal-title":"Nat. Cell Biol."},{"key":"47774_CR39","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0076-6879(08)03612-4","volume":"452","author":"G Bjorkoy","year":"2009","unstructured":"Bjorkoy, G. et al. Monitoring autophagic degradation of p62\/SQSTM1. Methods Enzymol. 452, 181\u2013197. https:\/\/doi.org\/10.1016\/S0076-6879(08)03612-4 (2009).","journal-title":"Methods Enzymol."},{"key":"47774_CR40","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s11658-016-0031-z","volume":"21","author":"WJ Liu","year":"2016","unstructured":"Liu, W. J. et al. p62 links the autophagy pathway and the ubiqutin-proteasome system upon ubiquitinated protein degradation. Cell Mol. Biol. Lett. 21, 29. https:\/\/doi.org\/10.1186\/s11658-016-0031-z (2016).","journal-title":"Cell Mol. Biol. Lett."},{"key":"47774_CR41","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.21037\/tlcr-20-1072","volume":"9","author":"S Huang","year":"2020","unstructured":"Huang, S. et al. Metformin reverses chemoresistance in non-small cell lung cancer via accelerating ubiquitination-mediated degradation of Nrf2. Transl. Lung Cancer Res. 9, 2337\u20132355. https:\/\/doi.org\/10.21037\/tlcr-20-1072 (2020).","journal-title":"Transl. Lung Cancer Res."},{"key":"47774_CR42","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.dib.2016.02.085","volume":"7","author":"R Gomez-Sanchez","year":"2016","unstructured":"Gomez-Sanchez, R. et al. mRNA and protein dataset of autophagy markers (LC3 and p62) in several cell lines. Data Brief. 7, 641\u2013647. https:\/\/doi.org\/10.1016\/j.dib.2016.02.085 (2016).","journal-title":"Data Brief."},{"key":"47774_CR43","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrd.2018.168","volume":"18","author":"S Pushpakom","year":"2019","unstructured":"Pushpakom, S. et al. Drug repurposing: Progress, challenges and recommendations. Nat. Rev. Drug. Discov. 18, 41\u201358. https:\/\/doi.org\/10.1038\/nrd.2018.168 (2019).","journal-title":"Nat. Rev. Drug. Discov."},{"key":"47774_CR44","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.arr.2017.08.003","volume":"40","author":"JM Campbell","year":"2017","unstructured":"Campbell, J. M., Bellman, S. M., Stephenson, M. D. & Lisy, K. Metformin reduces all-cause mortality and diseases of ageing independent of its effect on diabetes control: A systematic review and meta-analysis. Ageing Res. Rev. 40, 31\u201344. https:\/\/doi.org\/10.1016\/j.arr.2017.08.003 (2017).","journal-title":"Ageing Res. Rev."},{"key":"47774_CR45","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1161\/CIRCULATIONAHA.117.031735","volume":"137","author":"G Rena","year":"2018","unstructured":"Rena, G. & Lang, C. C. Repurposing metformin for cardiovascular disease. Circulation 137, 422\u2013424. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.117.031735 (2018).","journal-title":"Circulation"},{"key":"47774_CR46","doi-asserted-by":"publisher","first-page":"635","DOI":"10.3389\/fphar.2020.00635","volume":"11","author":"M Deng","year":"2020","unstructured":"Deng, M. et al. Metformin and vascular diseases: A focused review on smooth muscle cell function. Front. Pharmacol. 11, 635. https:\/\/doi.org\/10.3389\/fphar.2020.00635 (2020).","journal-title":"Front. Pharmacol."},{"key":"47774_CR47","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.avsg.2018.05.054","volume":"55","author":"SZ Khan","year":"2019","unstructured":"Khan, S. Z. et al. Metformin is associated with improved survival and decreased cardiac events with no impact on patency and limb salvage after revascularization for peripheral arterial disease. Ann. Vasc. Surg. 55, 63\u201377. https:\/\/doi.org\/10.1016\/j.avsg.2018.05.054 (2019).","journal-title":"Ann. Vasc. Surg."},{"key":"47774_CR48","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.molmet.2018.11.002","volume":"20","author":"JC Wilmanns","year":"2019","unstructured":"Wilmanns, J. C. et al. Metformin intervention prevents cardiac dysfunction in a murine model of adult congenital heart disease. Mol. Metab. 20, 102\u2013114. https:\/\/doi.org\/10.1016\/j.molmet.2018.11.002 (2019).","journal-title":"Mol. Metab."},{"key":"47774_CR49","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12933-017-0509-7","volume":"16","author":"A Mary","year":"2017","unstructured":"Mary, A. et al. Association between metformin use and below-the-knee arterial calcification score in type 2 diabetic patients. Cardiovasc. Diabetol. 16, 24. https:\/\/doi.org\/10.1186\/s12933-017-0509-7 (2017).","journal-title":"Cardiovasc. Diabetol."},{"key":"47774_CR50","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1097\/MOL.0000000000000532","volume":"29","author":"AJ Jenkins","year":"2018","unstructured":"Jenkins, A. J., Welsh, P. & Petrie, J. R. Metformin, lipids and atherosclerosis prevention. Curr. Opin. Lipidol. 29, 346\u2013353. https:\/\/doi.org\/10.1097\/MOL.0000000000000532 (2018).","journal-title":"Curr. Opin. Lipidol."},{"key":"47774_CR51","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3892\/etm.2020.9490","volume":"21","author":"X Qiu","year":"2021","unstructured":"Qiu, X. et al. Metformin alleviates beta-glycerophosphate-induced calcification of vascular smooth muscle cells via AMPK\/mTOR-activated autophagy. Exp. Ther. Med. 21, 58. https:\/\/doi.org\/10.3892\/etm.2020.9490 (2021).","journal-title":"Exp. Ther. Med."},{"key":"47774_CR52","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.2337\/db10-0351","volume":"60","author":"Z Xie","year":"2011","unstructured":"Xie, Z. et al. Improvement of cardiac functions by chronic metformin treatment is associated with enhanced cardiac autophagy in diabetic OVE26 mice. Diabetes 60, 1770\u20131778. https:\/\/doi.org\/10.2337\/db10-0351 (2011).","journal-title":"Diabetes"},{"key":"47774_CR53","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1038\/ki.2012.482","volume":"83","author":"XY Dai","year":"2013","unstructured":"Dai, X. Y. et al. Phosphate-induced autophagy counteracts vascular calcification by reducing matrix vesicle release. Kidney Int. 83, 1042\u20131051. https:\/\/doi.org\/10.1038\/ki.2012.482 (2013).","journal-title":"Kidney Int."},{"key":"47774_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2019.107430","volume":"206","author":"K Phadwal","year":"2020","unstructured":"Phadwal, K., Feng, D., Zhu, D. & MacRae, V. E. Autophagy as a novel therapeutic target in vascular calcification. Pharmacol. Ther. 206, 107430. https:\/\/doi.org\/10.1016\/j.pharmthera.2019.107430 (2020).","journal-title":"Pharmacol. Ther."},{"key":"47774_CR55","doi-asserted-by":"publisher","first-page":"15614","DOI":"10.1038\/s41598-017-15057-6","volume":"7","author":"JH Hervas","year":"2017","unstructured":"Hervas, J. H. et al. Human ATG3 binding to lipid bilayers: Role of lipid geometry, and electric charge. Sci. Rep. 7, 15614. https:\/\/doi.org\/10.1038\/s41598-017-15057-6 (2017).","journal-title":"Sci. Rep."},{"key":"47774_CR56","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.685625","volume":"9","author":"D Fang","year":"2021","unstructured":"Fang, D., Xie, H., Hu, T., Shan, H. & Li, M. Binding features and functions of ATG3. Front. Cell Dev. Biol. 9, 685625. https:\/\/doi.org\/10.3389\/fcell.2021.685625 (2021).","journal-title":"Front. Cell Dev. Biol."},{"key":"47774_CR57","doi-asserted-by":"publisher","first-page":"144","DOI":"10.3390\/ijms24021643","volume":"24","author":"K Phadwal","year":"2023","unstructured":"Phadwal, K. et al. p53 Regulates mitochondrial dynamics in vascular smooth muscle cell calcification. Int. J. Mol. Sci. 24, 144. https:\/\/doi.org\/10.3390\/ijms24021643 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"47774_CR58","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.mce.2018.08.012","volume":"479","author":"WQ Ma","year":"2019","unstructured":"Ma, W. Q. et al. Restoring mitochondrial biogenesis with metformin attenuates beta-GP-induced phenotypic transformation of VSMCs into an osteogenic phenotype via inhibition of PDK4\/oxidative stress-mediated apoptosis. Mol. Cell Endocrinol. 479, 39\u201353. https:\/\/doi.org\/10.1016\/j.mce.2018.08.012 (2019).","journal-title":"Mol. Cell Endocrinol."},{"key":"47774_CR59","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20061486","author":"M Carracedo","year":"2019","unstructured":"Carracedo, M. et al. Upregulated autophagy in calcific aortic valve stenosis confers protection of valvular interstitial cells. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms20061486 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"47774_CR60","doi-asserted-by":"publisher","DOI":"10.3389\/fpls.2021.783881","volume":"12","author":"W Liu","year":"2021","unstructured":"Liu, W. et al. ATG8-interacting motif: Evolution and function in selective autophagy of targeting biological processes. Front. Plant Sci. 12, 783881. https:\/\/doi.org\/10.3389\/fpls.2021.783881 (2021).","journal-title":"Front. Plant Sci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-47774-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-47774-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-47774-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,5]],"date-time":"2023-12-05T05:02:42Z","timestamp":1701752562000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-47774-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,5]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["47774"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-47774-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,5]]},"assertion":[{"value":"15 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21435"}}